MARCKS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.211000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.239400E-04
Normal-vs-Stage2
3.443600E-04
Normal-vs-Stage3
9.936100E-02
Normal-vs-Stage4
1.288470E-02
Stage1-vs-Stage2
1.137630E-01
Stage1-vs-Stage3
1.165450E-01
Stage1-vs-Stage4
9.280000E-02
Stage2-vs-Stage3
4.247800E-01
Stage2-vs-Stage4
8.026600E-01
Stage3-vs-Stage4
7.217600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.559200E-04
Normal-vs-AfricanAmerican
1.690440E-02
Normal-vs-Asian
1.061510E-02
Caucasian-vs-AfricanAmerican
8.004200E-01
Caucasian-vs-Asian
9.184200E-01
AfricanAmerican-vs-Asian
8.995600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.979800E-04
Normal-vs-Female
1.316280E-03
Male-vs-Female
2.806600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.106280E-02
Normal-vs-Age(41-60Yrs)
2.164200E-04
Normal-vs-Age(61-80Yrs)
1.018100E-03
Normal-vs-Age(81-100Yrs)
2.244200E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.907830E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.284200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.037400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.212060E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.340800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.002600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.988500E-04
Normal-vs-Daily Drinker
5.83779999999701E-05
Normal-vs-Weekly Drinker
1.506160E-02
Normal-vs-Occasional Drinker
3.573600E-02
Normal-vs-Social Drinker
2.320100E-02
Non Drinker-vs-Daily Drinker
6.184000E-01
Non Drinker-vs-Weekly Drinker
3.819000E-01
Non Drinker-vs-Occasional Drinker
1.571590E-01
Non Drinker-vs-Social Drinker
3.266400E-01
Daily Drinker-vs-Weekly Drinker
2.083800E-01
Daily Drinker-vs-Occasional Drinker
1.007810E-01
Daily Drinker-vs-Social Drinker
1.812620E-01
Weekly Drinker-vs-Occasional Drinker
6.905600E-01
Weekly Drinker-vs-Social Drinker
9.289400E-01
Occasional Drinker-vs-Social Drinker
7.604800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.738800E-01
Normal-vs-Grade 2
9.624800E-01
Normal-vs-Grade 3
9.445200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.677800E-01
Grade 1-vs-Grade 3
2.933800E-01
Grade 1-vs-Grade 4
9.738800E-01
Grade 2-vs-Grade 3
7.180800E-01
Grade 2-vs-Grade 4
9.624800E-01
Grade 3-vs-Grade 4
9.445200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.064900E-03
Normal-vs-NonDiabetic
6.819200E-04
Diabetic-vs-NonDiabetic
7.782600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.798300E-04
Normal-vs-NoPancreatitis
1.364110E-03
Pancreatitis-vs-NoPancreatitis
4.837200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.480000E-03
Normal-vs-N1
2.233300E-04
N0-vs-N1
7.682200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.041500E-03
Normal-vs-TP53-NonMutant
1.156740E-03
TP53-Mutant-vs-TP53-NonMutant
2.559200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
